Sponsor Pipeline

Orca Biosystems, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
1
Phase 3
5
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-25 NCT07346105
Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies		 overall status: Temporarily Not Available → Available
Active Trials by Phase
Phase 3
1
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05316701 Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic… Acute Myeloid Leukemia Active, Not Recruiting
Phase 2
NCT07216443 Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients… Leukemia, Myeloid, Acute Recruiting
Phase 1
NCT03802695 A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for… Acute Myeloid Leukemia Recruiting
NCT04013685 Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for… Acute Myeloid Leukemia Active, Not Recruiting
Disease Areas
Leukemia (4) Myelodysplastic Syndromes (MDS) (4) Acute Myeloid Leukemia (AML) (3) Acute Lymphoblastic Leukemia (ALL) (1) Chronic Myeloid Leukemia (CML) (1)
Get alerts when Orca Biosystems, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free